Recipharm CEO sells shares - remains committed and significant holder
Thomas Eldered, CEO and co-founder of Recipharm AB, has informed the Company that he has sold 1,559,125 Class B shares in Recipharm, representing approximately 12.7% of his total shareholding in the Company, to a Swedish institutional investor. Following the transaction, Thomas Eldered remains the single largest shareholder in Recipharm and holds 15.8% of the shares and 38.7% of the votes in the Company. Thomas commented: “There are only personal financial reasons behind the decision to sell a small portion of my shares in Recipharm. I have no intention to sell any additional shares in